Impact of Research Site Selection on Study Participant Diversity in Device Trials | Insights From the US FDA COOP Registry

Saturday, March 7, 2026

8:00 AM - 8:08 AM EST

Location: Cabinet

Speaker(s)

Joaquin E. Cigarroa, MD

Director, Knight Cardiovascular Institute
OHSU Knight Cardiovascular Institute
Portland, Oregon, United States

Disclosure information not submitted.

Disclosure(s):

Wayne Batchelor, MD, MHS, MBA: Abbott Vascular, Edwards, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing); Johnson and Johnson: Consulting Fees (e.g., advisory boards) (Ongoing); Recor Medical, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing)